Key result
Chronic renal failure impairs mouse cerebral endothelial relaxation, linked to decreased PPARγ and elevated ADMA.
Why the study?
Does chronic renal failure alter endothelial function in cerebral circulation in mice?
Does chronic renal failure alter endothelial function in cerebral circulation in mice?
In a mouse model, early-stage chronic renal failure impairs cerebral endothelial function, likely driven by decreased nitric oxide production.
Answers are grounded in this paper and cite their sources.
Suggests cerebrovascular endothelial risk in CKD; hypothesis-generating and requires human validation before clinical relevance.
We examined structure, composition, and endothelial function in cerebral arterioles after 4 wk of chronic renal failure (CRF) in a well-defined murine model (C57BL/6J and apolipoprotein E knockout female mice). We also determined quantitative expression of endothelial nitric oxide synthase (eNOS), phosphorylated eNOS (on serine 1177 and threonine 495), and caveolin-1; quantitative expression of markers of vascular inflammation or oxidative stress [Rock-1, Rock-2, VCAM-1, and peroxisome proliferator-activated receptor-γ (PPARγ)]; and the plasma concentration of L-arginine and asymmetric dimethylarginine (ADMA). Our hypothesis was that endothelial function would be impaired in cerebral arterioles during CRF following either a decrease in NO production (through alteration of eNOS expression or regulation) or an increase in NO degradation (due to oxidative stress or vascular inflammation). Endothelium-dependent relaxation was impaired during CRF, but endothelium-independent relaxation was not. CRF had no effect on cerebral arteriolar structure and composition. Quantitative expressions of eNOS, eNOS phosphorylated on serine 1177, caveolin-1, Rock-1, Rock-2, and VCAM-1 were similar in CRF and non-CRF mice. In contrast, quantitative expression of PPARγ (which exercises a protective role on blood vessels) was significantly lower in CRF mice, whereas quantitative expression of eNOS phosphorylated on the threonine 495 (the inactive form of eNOS) was significantly higher. Lastly, the plasma concentration of ADMA (a uremic toxin and an endogenous inhibitor of eNOS) was elevated and plasma concentration of L-arginine was low in CRF. In conclusion, endothelial function is impaired in a mouse model of early stage CRF. These alterations may be related (at least in part) to a decrease in NO production.
No takes yet. Share an insight, caveat, or question.
Bugnicourt et al. (2011) studied Chronic renal failure. Chronic renal failure vs. non-CRF mice was evaluated on Endothelium-dependent relaxation and quantitative expression of eNOS, PPARγ, ADMA, and L-arginine. In a mouse model, 4 weeks of chronic renal failure impaired endothelium-dependent relaxation in cerebral arterioles, associated with decreased PPARγ, increased inactive eNOS, and elevated ADMA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: